Treatment | Page 375 of 465

Crohn’s Disease :: Promising results in tough-to-treat crohn’s disease patients

Abbott announced results from a study showing HUMIRA? (adalimumab) induced significantly higher rates of clinical remission compared to placebo in patients with moderately to severely active Crohn’s disease who lost response to, or were intolerant to, infliximab therapy. The data is being presented simultaneously at the American College of Gastroenterology (ACG) annual meeting in Las Vegas and the United European Gastroenterology Week (UEGW) in Berlin.

Colorectal Cancer :: Mesalazine to prevent colorectal cancer in IBD

Speaking at a Ferring-sponsored symposium on the occasion of the 14th United European Gastroenterology Week (UEGW) congress, Christoph Gasche, Associate Professor of Medicine, Medical University of Vienna, Austria presented the findings of an in-vitro study which for the first time demonstrates a mode of action by which mesalazine may reduce the risk of colorectal cancer in Inflammatory Bowel Disease (IBD) patients.

Dental Health :: Promising Approach to Prevent Tooth Decay

Preventing cavities could one day involve the dental equivalent of a military surgical strike. A team of researchers supported by the National Institute of Dental and Craniofacial Research report they have created a new smart anti-microbial treatment that can be chemically programmed in the laboratory to seek out and kill a specific cavity-causing species of bacteria, leaving the good bacteria untouched.

Heart Disease :: Painkillers, ibuprofen can increase the risk of heart attacks

A class of painkillers which includes ibuprofen can increase the risk of heart attacks if taken over long periods. The Commission on Human Medicines (CHM) has written to every doctor in the UK warning them that non-steroidal anti-inflammatory drugs (NSAIDs) – which are routinely taken by arthritis and back pain sufferers – “may be associated with a small risk of heart attack or stroke” when used for long-term treatment.

Cancer :: Gene activation test for right cancer chemotherapy treatment

A new test could now be able to improve doctors’ ability to recommend the right type of cancer treatment for their patients. According to the researchers, the test, which has been developed by Anil Potti at the Duke Institute for Genome Sciences and Policy in Durham, North Carolina, is 80% accurate in predicting the right chemotherapy to cure each person’s cancer.

Fertility :: Motherhood, parenting easier for older women

Women who give birth in their 50s are just as able to cope with motherhood as younger women, according to a study by fertility specialists. Surveys of older women having fertility treatment showed they found parenting no more stressful or physically demanding than women in their 30s and 40s, and theyshowed no signs of poorer mental health possibly brought on by feelings of isolation.

Health :: Gene therapy in inherited disorders

In a significant breakthrough in gene therapy, scientists of the Indian Institute of Chemical Biology (IICB) here claimed to have isolated a protein molecule from a parasite that will provide better treatment in some inherited disorders.

Allergy :: Altana’s Omnaris, ciclesonide nasal spray for allergies, allergic rhinitis, hay fever

The Food and Drug Administration (FDA) announced the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.

Health :: Smarter working and improved productivity

Tackling wide variation could deliver benefits for patient care and better value for money. Improved NHS productivity and better efficiency could unlock resources worth ?2.2bn for the NHS and improve patient care at the same time, Health Minister Andy Burnham said today.

Imaging :: Philips streamlines cath lab care and management

Royal Philips (NYSE: PHG, AEX: PHI) will showcase innovative cardiac solutions designed to streamline workflow and facilitate advanced information management at Cardiovascular Research Foundation?s (CRF) eighteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C.Shown for the first time ever in the U.S., the pre-release of the Philips Xcelera 2.1 Cardiovascular Information Solution is one of the key components to Philips integrated catheterization (cath) lab, which includes physiomonitoring, reporting and cardiovascular X-ray technologies to improve patient care and lab management.